Trump will sign FDA user fee reauthorization bill, ending threat of agency layoffs
Ahead of its summer recess, the US Senate today followed its House counterparts and passed a bipartisan bill to reauthorize FDA user fee programs for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
